_MEMBER_MyList,_LogP_MyList,GO,Description,_PATTERN_,_RANK_,GiniIndex
1,-2.1,GO:0090190,positive regulation of branching involved in ureteric bud morphogenesis,M1,1,0
1,-11,GO:2000147,positive regulation of cell motility,M1,1,0
1,-8.8,GO:0030155,regulation of cell adhesion,M1,1,0
1,-2.2,GO:0014020,primary neural tube formation,M1,1,0
1,-2.8,GO:0010454,negative regulation of cell fate commitment,M1,1,0
1,-2.4,GO:0046470,phosphatidylcholine metabolic process,M1,1,0
1,-2.7,GO:0062012,regulation of small molecule metabolic process,M1,1,0
1,-3,GO:0030032,lamellipodium assembly,M1,1,0
1,-3,GO:0042454,ribonucleoside catabolic process,M1,1,0
1,-2.4,GO:0043094,cellular metabolic compound salvage,M1,1,0
1,-4.5,GO:0070493,thrombin-activated receptor signaling pathway,M1,1,0
1,-6.8,GO:0001568,blood vessel development,M1,1,0
1,-5.9,GO:0001525,angiogenesis,M1,1,0
1,-2.5,GO:0001823,mesonephros development,M1,1,0
1,-3.6,GO:0045745,positive regulation of G protein-coupled receptor signaling pathway,M1,1,0
1,-2.8,GO:0045823,positive regulation of heart contraction,M1,1,0
1,-2.8,GO:0046329,negative regulation of JNK cascade,M1,1,0
1,-3.8,R-HSA-8957275,Post-translational protein phosphorylation,M1,1,0
1,-2.3,GO:0060541,respiratory system development,M1,1,0
1,-7.9,GO:0010959,regulation of metal ion transport,M1,1,0
1,-4.1,GO:0008643,carbohydrate transport,M1,1,0
1,-3.3,GO:0032872,regulation of stress-activated MAPK cascade,M1,1,0
1,-2.4,GO:1901016,regulation of potassium ion transmembrane transporter activity,M1,1,0
1,-8.5,M5885,NABA MATRISOME ASSOCIATED,M1,1,0
1,-5.2,GO:0003158,endothelium development,M1,1,0
1,-3.4,GO:0097190,apoptotic signaling pathway,M1,1,0
1,-6.4,R-HSA-1474244,Extracellular matrix organization,M1,1,0
1,-4.8,GO:0006643,membrane lipid metabolic process,M1,1,0
1,-4.9,GO:0045229,external encapsulating structure organization,M1,1,0
1,-5.3,GO:0030900,forebrain development,M1,1,0
1,-3,GO:0034110,regulation of homotypic cell-cell adhesion,M1,1,0
1,-2.3,GO:1901606,alpha-amino acid catabolic process,M1,1,0
1,-4.2,GO:1901652,response to peptide,M1,1,0
1,-2.2,GO:0030031,cell projection assembly,M1,1,0
1,-10,GO:0010035,response to inorganic substance,M1,1,0
1,-2.2,GO:0045217,cell-cell junction maintenance,M1,1,0
1,-2.1,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,M1,1,0
1,-2.8,GO:0006692,prostanoid metabolic process,M1,1,0
1,-3.4,GO:0097746,blood vessel diameter maintenance,M1,1,0
1,-2.2,GO:0032355,response to estradiol,M1,1,0
1,-2.4,GO:0050709,negative regulation of protein secretion,M1,1,0
1,-4.4,GO:0006836,neurotransmitter transport,M1,1,0
1,-2.5,GO:0010561,negative regulation of glycoprotein biosynthetic process,M1,1,0
1,-2.3,GO:0033137,negative regulation of peptidyl-serine phosphorylation,M1,1,0
1,-2.9,GO:0051156,glucose 6-phosphate metabolic process,M1,1,0
1,-4.3,GO:0032102,negative regulation of response to external stimulus,M1,1,0
1,-5.9,GO:0002690,positive regulation of leukocyte chemotaxis,M1,1,0
1,-2.1,GO:0006575,cellular modified amino acid metabolic process,M1,1,0
1,-2.6,GO:0097581,lamellipodium organization,M1,1,0
1,-4.9,GO:0044062,regulation of excretion,M1,1,0
1,-2.1,GO:0045055,regulated exocytosis,M1,1,0
1,-2.1,GO:0070167,regulation of biomineral tissue development,M1,1,0
1,-6.5,GO:0090257,regulation of muscle system process,M1,1,0
1,-3.2,GO:0071470,cellular response to osmotic stress,M1,1,0
1,-3,GO:0002263,cell activation involved in immune response,M1,1,0
1,-2.3,GO:0032873,negative regulation of stress-activated MAPK cascade,M1,1,0
1,-3.4,GO:0010876,lipid localization,M1,1,0
1,-5.7,GO:0032409,regulation of transporter activity,M1,1,0
1,-2.9,GO:0060401,cytosolic calcium ion transport,M1,1,0
1,-4.6,GO:0051048,negative regulation of secretion,M1,1,0
1,-2.6,GO:0010713,negative regulation of collagen metabolic process,M1,1,0
1,-4.5,GO:0032103,positive regulation of response to external stimulus,M1,1,0
1,-3.9,GO:0008285,negative regulation of cell population proliferation,M1,1,0
1,-3.4,GO:0007568,aging,M1,1,0
1,-2.3,GO:1903793,positive regulation of anion transport,M1,1,0
1,-2.1,WP244,Alpha 6 beta 4 signaling pathway,M1,1,0
1,-2.3,GO:0044706,multi-multicellular organism process,M1,1,0
1,-2.8,GO:2000146,negative regulation of cell motility,M1,1,0
1,-4.2,GO:0006520,cellular amino acid metabolic process,M1,1,0
1,-4.4,GO:0061045,negative regulation of wound healing,M1,1,0
1,-5.6,GO:0043271,negative regulation of ion transport,M1,1,0
1,-2.3,GO:0045780,positive regulation of bone resorption,M1,1,0
1,-3.4,hsa00561,Glycerolipid metabolism,M1,1,0
1,-3.3,GO:0071241,cellular response to inorganic substance,M1,1,0
1,-3.2,GO:0010976,positive regulation of neuron projection development,M1,1,0
1,-4.9,GO:0048589,developmental growth,M1,1,0
1,-3.2,GO:0003012,muscle system process,M1,1,0
1,-6.8,GO:0048729,tissue morphogenesis,M1,1,0
1,-3.3,GO:0045137,development of primary sexual characteristics,M1,1,0
1,-3.8,GO:0043547,positive regulation of GTPase activity,M1,1,0
1,-2.3,GO:1902624,positive regulation of neutrophil migration,M1,1,0
1,-4.1,GO:0072009,nephron epithelium development,M1,1,0
1,-2.2,R-HSA-418990,Adherens junctions interactions,M1,1,0
1,-4.4,GO:0007596,blood coagulation,M1,1,0
1,-2,GO:0055001,muscle cell development,M1,1,0
1,-3.4,GO:0032535,regulation of cellular component size,M1,1,0
1,-7.7,GO:1901137,carbohydrate derivative biosynthetic process,M1,1,0
1,-11,GO:0040017,positive regulation of locomotion,M1,1,0
1,-2.1,hsa04150,mTOR signaling pathway,M1,1,0
1,-2.6,GO:0045833,negative regulation of lipid metabolic process,M1,1,0
1,-12,GO:0030855,epithelial cell differentiation,M1,1,0
1,-5.2,GO:0030195,negative regulation of blood coagulation,M1,1,0
1,-2.9,R-HSA-2562578,TRIF-mediated programmed cell death,M1,1,0
1,-2.7,GO:0042471,ear morphogenesis,M1,1,0
1,-7.6,GO:0072337,modified amino acid transport,M1,1,0
1,-2.2,GO:0031669,cellular response to nutrient levels,M1,1,0
1,-2.8,GO:1901264,carbohydrate derivative transport,M1,1,0
1,-3.5,GO:0046903,secretion,M1,1,0
1,-2.3,hsa04310,Wnt signaling pathway,M1,1,0
1,-2.7,GO:0033574,response to testosterone,M1,1,0
1,-3.9,GO:0010952,positive regulation of peptidase activity,M1,1,0
1,-3.1,GO:0002366,leukocyte activation involved in immune response,M1,1,0
1,-4.3,GO:0003093,regulation of glomerular filtration,M1,1,0
1,-7.4,GO:0008015,blood circulation,M1,1,0
1,-2,WP185,Integrin-mediated cell adhesion,M1,1,0
1,-2.8,GO:0090527,actin filament reorganization,M1,1,0
1,-5.1,GO:0050803,regulation of synapse structure or activity,M1,1,0
1,-3.1,GO:0048812,neuron projection morphogenesis,M1,1,0
1,-2.4,hsa04670,Leukocyte transendothelial migration,M1,1,0
1,-3.2,GO:0046320,regulation of fatty acid oxidation,M1,1,0
1,-2.9,GO:0051896,regulation of protein kinase B signaling,M1,1,0
1,-2.1,GO:0002093,auditory receptor cell morphogenesis,M1,1,0
1,-2.6,GO:0072506,trivalent inorganic anion homeostasis,M1,1,0
1,-2.9,GO:0046330,positive regulation of JNK cascade,M1,1,0
1,-3.4,GO:0035150,regulation of tube size,M1,1,0
1,-3.2,GO:0051482,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,M1,1,0
1,-5.7,GO:0099177,regulation of trans-synaptic signaling,M1,1,0
1,-2.2,R-HSA-5619115,Disorders of transmembrane transporters,M1,1,0
1,-13,GO:0044057,regulation of system process,M1,1,0
1,-3.6,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,M1,1,0
1,-11,GO:0050878,regulation of body fluid levels,M1,1,0
1,-6.1,GO:0032414,positive regulation of ion transmembrane transporter activity,M1,1,0
1,-7,GO:0045859,regulation of protein kinase activity,M1,1,0
1,-2.2,GO:0001890,placenta development,M1,1,0
1,-3.9,GO:0055086,nucleobase-containing small molecule metabolic process,M1,1,0
1,-4.4,GO:0008366,axon ensheathment,M1,1,0
1,-3.5,hsa05418,Fluid shear stress and atherosclerosis,M1,1,0
1,-6.5,GO:0022898,regulation of transmembrane transporter activity,M1,1,0
1,-2.8,GO:0090175,regulation of establishment of planar polarity,M1,1,0
1,-8.2,GO:0050818,regulation of coagulation,M1,1,0
1,-3.5,GO:0001775,cell activation,M1,1,0
1,-8.9,GO:0072507,divalent inorganic cation homeostasis,M1,1,0
1,-2.7,GO:0010591,regulation of lamellipodium assembly,M1,1,0
1,-3.1,R-HSA-352230,Amino acid transport across the plasma membrane,M1,1,0
1,-2.2,GO:2000369,regulation of clathrin-dependent endocytosis,M1,1,0
1,-2.2,R-HSA-4085001,Sialic acid metabolism,M1,1,0
1,-2.8,R-HSA-446107,Type I hemidesmosome assembly,M1,1,0
1,-2.7,GO:0032271,regulation of protein polymerization,M1,1,0
1,-2.7,GO:0000041,transition metal ion transport,M1,1,0
1,-2.8,GO:0035967,cellular response to topologically incorrect protein,M1,1,0
1,-3.1,GO:1901216,positive regulation of neuron death,M1,1,0
1,-3.3,WP2884,NRF2 pathway,M1,1,0
1,-5.7,R-HSA-416476,G alpha (q) signalling events,M1,1,0
1,-2.3,GO:0009798,axis specification,M1,1,0
1,-3,GO:0009267,cellular response to starvation,M1,1,0
1,-2.2,GO:0030168,platelet activation,M1,1,0
1,-2.5,GO:1903018,regulation of glycoprotein metabolic process,M1,1,0
1,-5.8,GO:0006937,regulation of muscle contraction,M1,1,0
1,-2.8,GO:0030194,positive regulation of blood coagulation,M1,1,0
1,-3.3,GO:0051146,striated muscle cell differentiation,M1,1,0
1,-2.1,GO:0006631,fatty acid metabolic process,M1,1,0
1,-2.3,GO:0051283,negative regulation of sequestering of calcium ion,M1,1,0
1,-2.3,hsa04140,Autophagy - animal,M1,1,0
1,-3.9,GO:0010762,regulation of fibroblast migration,M1,1,0
1,-4,GO:0051592,response to calcium ion,M1,1,0
1,-3.2,GO:0032970,regulation of actin filament-based process,M1,1,0
1,-5.5,GO:0006664,glycolipid metabolic process,M1,1,0
1,-2.9,GO:0045661,regulation of myoblast differentiation,M1,1,0
1,-3,GO:0043268,positive regulation of potassium ion transport,M1,1,0
1,-4.4,GO:0060491,regulation of cell projection assembly,M1,1,0
1,-2.6,GO:0030336,negative regulation of cell migration,M1,1,0
1,-2.1,GO:0071318,cellular response to ATP,M1,1,0
1,-2.1,GO:0086013,membrane repolarization during cardiac muscle cell action potential,M1,1,0
1,-3.3,GO:0007176,regulation of epidermal growth factor-activated receptor activity,M1,1,0
1,-2.1,GO:0110149,regulation of biomineralization,M1,1,0
1,-4.4,GO:0030890,positive regulation of B cell proliferation,M1,1,0
1,-2.2,GO:0048562,embryonic organ morphogenesis,M1,1,0
1,-5.9,GO:0032870,cellular response to hormone stimulus,M1,1,0
1,-3.4,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,M1,1,0
1,-3.4,GO:0030002,cellular anion homeostasis,M1,1,0
1,-3.4,hsa04978,Mineral absorption,M1,1,0
1,-4.9,GO:0040007,growth,M1,1,0
1,-2.7,GO:0009065,glutamine family amino acid catabolic process,M1,1,0
1,-2.7,hsa04514,Cell adhesion molecules,M1,1,0
1,-8.4,GO:0098662,inorganic cation transmembrane transport,M1,1,0
1,-2,GO:0001501,skeletal system development,M1,1,0
1,-8.3,GO:0010810,regulation of cell-substrate adhesion,M1,1,0
1,-2.8,WP5083,Neuroinflammation and glutamatergic signaling,M1,1,0
1,-3.5,GO:0055067,monovalent inorganic cation homeostasis,M1,1,0
1,-4.2,GO:0045987,positive regulation of smooth muscle contraction,M1,1,0
1,-5.7,GO:0050678,regulation of epithelial cell proliferation,M1,1,0
1,-2.2,GO:0033865,nucleoside bisphosphate metabolic process,M1,1,0
1,-7,GO:1902532,negative regulation of intracellular signal transduction,M1,1,0
1,-2.3,GO:0060078,regulation of postsynaptic membrane potential,M1,1,0
1,-2,GO:0071456,cellular response to hypoxia,M1,1,0
1,-2.9,GO:0046503,glycerolipid catabolic process,M1,1,0
1,-2.4,GO:0040018,positive regulation of multicellular organism growth,M1,1,0
1,-3.3,GO:0032677,regulation of interleukin-8 production,M1,1,0
1,-3.5,GO:0071900,regulation of protein serine/threonine kinase activity,M1,1,0
1,-4.6,GO:1903522,regulation of blood circulation,M1,1,0
1,-2.1,GO:0060402,calcium ion transport into cytosol,M1,1,0
1,-2.3,GO:0006654,phosphatidic acid biosynthetic process,M1,1,0
1,-2.7,GO:0002792,negative regulation of peptide secretion,M1,1,0
1,-12,GO:0009611,response to wounding,M1,1,0
1,-2.1,GO:0070293,renal absorption,M1,1,0
1,-4.4,GO:0046395,carboxylic acid catabolic process,M1,1,0
1,-2.3,GO:0006576,cellular biogenic amine metabolic process,M1,1,0
1,-6.8,GO:0098739,import across plasma membrane,M1,1,0
1,-2.4,GO:1902305,regulation of sodium ion transmembrane transport,M1,1,0
1,-2.2,GO:0050773,regulation of dendrite development,M1,1,0
1,-2.1,GO:0008360,regulation of cell shape,M1,1,0
1,-2.3,GO:1901185,negative regulation of ERBB signaling pathway,M1,1,0
1,-2,GO:0008064,regulation of actin polymerization or depolymerization,M1,1,0
1,-2.5,GO:0060538,skeletal muscle organ development,M1,1,0
1,-11,GO:1903034,regulation of response to wounding,M1,1,0
1,-5.6,GO:0090066,regulation of anatomical structure size,M1,1,0
1,-4.1,GO:0060627,regulation of vesicle-mediated transport,M1,1,0
1,-4.9,hsa05231,Choline metabolism in cancer,M1,1,0
1,-2.3,GO:0006506,GPI anchor biosynthetic process,M1,1,0
1,-5.4,GO:0050920,regulation of chemotaxis,M1,1,0
1,-2.6,GO:0006661,phosphatidylinositol biosynthetic process,M1,1,0
1,-2.1,hsa00512,Mucin type O-glycan biosynthesis,M1,1,0
1,-4.6,GO:0044242,cellular lipid catabolic process,M1,1,0
1,-5.2,R-HSA-196854,Metabolism of vitamins and cofactors,M1,1,0
1,-2.1,GO:0080135,regulation of cellular response to stress,M1,1,0
1,-2.2,hsa05010,Alzheimer disease,M1,1,0
1,-3.5,R-HSA-9013149,RAC1 GTPase cycle,M1,1,0
1,-4.7,GO:0035725,sodium ion transmembrane transport,M1,1,0
1,-2.8,R-HSA-196780,Biotin transport and metabolism,M1,1,0
1,-2.2,GO:0051402,neuron apoptotic process,M1,1,0
1,-8,GO:0010038,response to metal ion,M1,1,0
1,-2.2,GO:0008652,cellular amino acid biosynthetic process,M1,1,0
1,-7.7,GO:0055074,calcium ion homeostasis,M1,1,0
1,-2.2,GO:0002285,lymphocyte activation involved in immune response,M1,1,0
1,-2.1,GO:0030262,apoptotic nuclear changes,M1,1,0
1,-2.1,GO:0048017,inositol lipid-mediated signaling,M1,1,0
1,-2.3,GO:0035304,regulation of protein dephosphorylation,M1,1,0
1,-3.4,GO:2001056,positive regulation of cysteine-type endopeptidase activity,M1,1,0
1,-3.6,GO:0019233,sensory perception of pain,M1,1,0
1,-3.6,GO:0006753,nucleoside phosphate metabolic process,M1,1,0
1,-3,GO:0008584,male gonad development,M1,1,0
1,-5,GO:0048167,regulation of synaptic plasticity,M1,1,0
1,-2.3,GO:0032890,regulation of organic acid transport,M1,1,0
1,-2.2,R-HSA-112043,PLC beta mediated events,M1,1,0
1,-6.5,GO:0046942,carboxylic acid transport,M1,1,0
1,-2.7,GO:1901888,regulation of cell junction assembly,M1,1,0
1,-2.1,GO:0048872,homeostasis of number of cells,M1,1,0
1,-2.3,GO:0050671,positive regulation of lymphocyte proliferation,M1,1,0
1,-9,GO:0055065,metal ion homeostasis,M1,1,0
1,-2.7,GO:0010559,regulation of glycoprotein biosynthetic process,M1,1,0
1,-4.5,GO:0070372,regulation of ERK1 and ERK2 cascade,M1,1,0
1,-4,GO:0042311,vasodilation,M1,1,0
1,-2.1,GO:0140448,signaling receptor ligand precursor processing,M1,1,0
1,-3.6,GO:0046488,phosphatidylinositol metabolic process,M1,1,0
1,-4,GO:0002011,morphogenesis of an epithelial sheet,M1,1,0
1,-3.5,GO:0007268,chemical synaptic transmission,M1,1,0
1,-2.9,hsa01250,Biosynthesis of nucleotide sugars,M1,1,0
1,-3.5,GO:1901379,regulation of potassium ion transmembrane transport,M1,1,0
1,-4.6,GO:0048598,embryonic morphogenesis,M1,1,0
1,-5.6,GO:0002685,regulation of leukocyte migration,M1,1,0
1,-4.1,GO:0051928,positive regulation of calcium ion transport,M1,1,0
1,-2.3,GO:0003180,aortic valve morphogenesis,M1,1,0
1,-3.1,hsa00051,Fructose and mannose metabolism,M1,1,0
1,-5.4,GO:0050921,positive regulation of chemotaxis,M1,1,0
1,-3.1,hsa04014,Ras signaling pathway,M1,1,0
1,-3.5,GO:0062197,cellular response to chemical stress,M1,1,0
1,-3.6,GO:0061098,positive regulation of protein tyrosine kinase activity,M1,1,0
1,-4.5,GO:0050673,epithelial cell proliferation,M1,1,0
1,-2.9,GO:0070472,regulation of uterine smooth muscle contraction,M1,1,0
1,-2.1,GO:0070373,negative regulation of ERK1 and ERK2 cascade,M1,1,0
1,-12,GO:0003013,circulatory system process,M1,1,0
1,-2.2,R-HSA-2871809,FCERI mediated Ca+2 mobilization,M1,1,0
1,-3.8,R-HSA-1483206,Glycerophospholipid biosynthesis,M1,1,0
1,-2.3,GO:0007409,axonogenesis,M1,1,0
1,-2.4,GO:0051491,positive regulation of filopodium assembly,M1,1,0
1,-2.4,GO:0010939,regulation of necrotic cell death,M1,1,0
1,-2.6,GO:0045741,positive regulation of epidermal growth factor-activated receptor activity,M1,1,0
1,-2.8,hsa05412,Arrhythmogenic right ventricular cardiomyopathy,M1,1,0
1,-7.7,GO:0034765,regulation of ion transmembrane transport,M1,1,0
1,-2.7,GO:1903524,positive regulation of blood circulation,M1,1,0
1,-6.7,GO:0048871,multicellular organismal homeostasis,M1,1,0
1,-2.4,GO:0097066,response to thyroid hormone,M1,1,0
1,-3.3,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,M1,1,0
1,-2.3,GO:0090162,establishment of epithelial cell polarity,M1,1,0
1,-2.7,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,M1,1,0
1,-3,GO:0099504,synaptic vesicle cycle,M1,1,0
1,-3.7,hsa04066,HIF-1 signaling pathway,M1,1,0
1,-2.4,GO:0045596,negative regulation of cell differentiation,M1,1,0
1,-2.2,R-HSA-937072,TRAF6-mediated induction of TAK1 complex within TLR4 complex,M1,1,0
1,-2.8,M158,PID INTEGRIN4 PATHWAY,M1,1,0
1,-4.1,GO:0043405,regulation of MAP kinase activity,M1,1,0
1,-2.8,GO:0070228,regulation of lymphocyte apoptotic process,M1,1,0
1,-2.4,GO:1903019,negative regulation of glycoprotein metabolic process,M1,1,0
1,-4.7,GO:0002687,positive regulation of leukocyte migration,M1,1,0
1,-4.9,GO:0051346,negative regulation of hydrolase activity,M1,1,0
1,-3.2,GO:0032990,cell part morphogenesis,M1,1,0
1,-2.5,R-HSA-9033241,Peroxisomal protein import,M1,1,0
1,-2.7,GO:0007566,embryo implantation,M1,1,0
1,-2.3,GO:0050808,synapse organization,M1,1,0
1,-4.4,GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,M1,1,0
1,-2.2,GO:0046394,carboxylic acid biosynthetic process,M1,1,0
1,-2.5,GO:0072329,monocarboxylic acid catabolic process,M1,1,0
1,-4.1,GO:0016042,lipid catabolic process,M1,1,0
1,-2.3,GO:0097553,calcium ion transmembrane import into cytosol,M1,1,0
1,-2.1,R-HSA-422356,Regulation of insulin secretion,M1,1,0
1,-2.5,GO:0002903,negative regulation of B cell apoptotic process,M1,1,0
1,-2.6,GO:0044319,"wound healing, spreading of cells",M1,1,0
1,-2.8,GO:0032946,positive regulation of mononuclear cell proliferation,M1,1,0
1,-2.9,GO:0006935,chemotaxis,M1,1,0
1,-2.6,GO:0006869,lipid transport,M1,1,0
1,-2.6,GO:0001657,ureteric bud development,M1,1,0
1,-2.6,GO:0050714,positive regulation of protein secretion,M1,1,0
1,-4.9,GO:0007605,sensory perception of sound,M1,1,0
1,-2.1,hsa05165,Human papillomavirus infection,M1,1,0
1,-3.2,GO:0010662,regulation of striated muscle cell apoptotic process,M1,1,0
1,-2.9,GO:0032288,myelin assembly,M1,1,0
1,-2.1,hsa00500,Starch and sucrose metabolism,M1,1,0
1,-5.3,GO:1903036,positive regulation of response to wounding,M1,1,0
1,-5,GO:0043086,negative regulation of catalytic activity,M1,1,0
1,-2.3,R-HSA-5260271,Diseases of Immune System,M1,1,0
1,-3.9,GO:0002027,regulation of heart rate,M1,1,0
1,-4.4,WP2572,Primary focal segmental glomerulosclerosis (FSGS),M1,1,0
1,-4.7,GO:0071383,cellular response to steroid hormone stimulus,M1,1,0
1,-4.2,GO:0031175,neuron projection development,M1,1,0
1,-2.9,GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,M1,1,0
1,-2.1,GO:0044060,regulation of endocrine process,M1,1,0
1,-8.5,GO:1900046,regulation of hemostasis,M1,1,0
1,-2.5,R-HSA-1483191,Synthesis of PC,M1,1,0
1,-3.4,GO:0050865,regulation of cell activation,M1,1,0
1,-2.6,GO:0051960,regulation of nervous system development,M1,1,0
1,-2.3,GO:0042044,fluid transport,M1,1,0
1,-2.4,R-HSA-5668914,Diseases of metabolism,M1,1,0
1,-4,GO:0006954,inflammatory response,M1,1,0
1,-3.3,GO:0034976,response to endoplasmic reticulum stress,M1,1,0
1,-4.5,hsa05200,Pathways in cancer,M1,1,0
1,-3.7,GO:0071496,cellular response to external stimulus,M1,1,0
1,-7.9,GO:0034330,cell junction organization,M1,1,0
1,-2.2,GO:0090022,regulation of neutrophil chemotaxis,M1,1,0
1,-2.3,hsa00565,Ether lipid metabolism,M1,1,0
1,-3,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,M1,1,0
1,-2.4,GO:0090630,activation of GTPase activity,M1,1,0
1,-3.1,GO:0032874,positive regulation of stress-activated MAPK cascade,M1,1,0
1,-6.9,GO:0007167,enzyme linked receptor protein signaling pathway,M1,1,0
1,-2,R-HSA-446203,Asparagine N-linked glycosylation,M1,1,0
1,-2.3,GO:0071260,cellular response to mechanical stimulus,M1,1,0
1,-2.7,M166,PID ATF2 PATHWAY,M1,1,0
1,-3.1,GO:0071375,cellular response to peptide hormone stimulus,M1,1,0
1,-2.7,GO:0002224,toll-like receptor signaling pathway,M1,1,0
1,-4.6,GO:0002931,response to ischemia,M1,1,0
1,-4.8,GO:0045017,glycerolipid biosynthetic process,M1,1,0
1,-4.5,GO:0010466,negative regulation of peptidase activity,M1,1,0
1,-4.8,GO:0009612,response to mechanical stimulus,M1,1,0
1,-7.2,GO:0052547,regulation of peptidase activity,M1,1,0
1,-3.9,GO:0071417,cellular response to organonitrogen compound,M1,1,0
1,-3.1,GO:0070229,negative regulation of lymphocyte apoptotic process,M1,1,0
1,-5.8,GO:0061458,reproductive system development,M1,1,0
1,-3.9,GO:0030036,actin cytoskeleton organization,M1,1,0
1,-3.1,GO:0060054,positive regulation of epithelial cell proliferation involved in wound healing,M1,1,0
1,-3.4,GO:0050806,positive regulation of synaptic transmission,M1,1,0
1,-5.6,GO:0032411,positive regulation of transporter activity,M1,1,0
1,-7.5,GO:0098801,regulation of renal system process,M1,1,0
1,-3.2,M165,PID SYNDECAN 4 PATHWAY,M1,1,0
1,-2,WP516,Hypertrophy model,M1,1,0
1,-4.9,GO:1905039,carboxylic acid transmembrane transport,M1,1,0
1,-2.7,GO:2000377,regulation of reactive oxygen species metabolic process,M1,1,0
1,-3,GO:0023061,signal release,M1,1,0
1,-3.1,hsa05205,Proteoglycans in cancer,M1,1,0
1,-13,GO:0098771,inorganic ion homeostasis,M1,1,0
1,-2.8,hsa04918,Thyroid hormone synthesis,M1,1,0
1,-2.8,GO:0061314,Notch signaling involved in heart development,M1,1,0
1,-2.5,GO:0030004,cellular monovalent inorganic cation homeostasis,M1,1,0
1,-2.6,GO:2000050,regulation of non-canonical Wnt signaling pathway,M1,1,0
1,-2.3,GO:0051489,regulation of filopodium assembly,M1,1,0
1,-2.1,GO:0021511,spinal cord patterning,M1,1,0
1,-2.4,GO:0098659,inorganic cation import across plasma membrane,M1,1,0
1,-2.5,R-HSA-5357769,Caspase activation via extrinsic apoptotic signalling pathway,M1,1,0
1,-2.9,GO:1903829,positive regulation of protein localization,M1,1,0
1,-5.5,GO:0030029,actin filament-based process,M1,1,0
1,-2.7,M5883,NABA SECRETED FACTORS,M1,1,0
1,-2.1,GO:0035633,maintenance of blood-brain barrier,M1,1,0
1,-2.3,GO:0045471,response to ethanol,M1,1,0
1,-2.7,GO:0046887,positive regulation of hormone secretion,M1,1,0
1,-3.4,WP2882,Nuclear receptors meta-pathway,M1,1,0
1,-5.1,GO:0010942,positive regulation of cell death,M1,1,0
1,-2.8,GO:0035313,"wound healing, spreading of epidermal cells",M1,1,0
1,-4.6,GO:0006816,calcium ion transport,M1,1,0
1,-2.8,hsa04750,Inflammatory mediator regulation of TRP channels,M1,1,0
1,-3.4,hsa04919,Thyroid hormone signaling pathway,M1,1,0
1,-10,GO:0098660,inorganic ion transmembrane transport,M1,1,0
1,-2.4,GO:0051899,membrane depolarization,M1,1,0
1,-11,GO:0030001,metal ion transport,M1,1,0
1,-2.1,GO:0046513,ceramide biosynthetic process,M1,1,0
1,-2.7,GO:0097193,intrinsic apoptotic signaling pathway,M1,1,0
1,-2.5,GO:0034111,negative regulation of homotypic cell-cell adhesion,M1,1,0
1,-3.5,GO:0042692,muscle cell differentiation,M1,1,0
1,-4.2,GO:0010817,regulation of hormone levels,M1,1,0
1,-3.7,GO:0051591,response to cAMP,M1,1,0
1,-3.3,GO:0007610,behavior,M1,1,0
1,-2.2,GO:0048661,positive regulation of smooth muscle cell proliferation,M1,1,0
1,-3.4,GO:0042490,mechanoreceptor differentiation,M1,1,0
1,-3.4,GO:0061156,pulmonary artery morphogenesis,M1,1,0
1,-4,GO:0003014,renal system process,M1,1,0
1,-4.6,GO:0060562,epithelial tube morphogenesis,M1,1,0
1,-2.9,R-HSA-5686938,Regulation of TLR by endogenous ligand,M1,1,0
1,-3.3,GO:0021537,telencephalon development,M1,1,0
1,-3.2,GO:0010812,negative regulation of cell-substrate adhesion,M1,1,0
1,-6.6,GO:0006644,phospholipid metabolic process,M1,1,0
1,-2.1,GO:0099622,cardiac muscle cell membrane repolarization,M1,1,0
1,-2.4,hsa04973,Carbohydrate digestion and absorption,M1,1,0
1,-2.9,GO:0071223,cellular response to lipoteichoic acid,M1,1,0
1,-2.4,GO:0019228,neuronal action potential,M1,1,0
1,-2.8,GO:1901186,positive regulation of ERBB signaling pathway,M1,1,0
1,-3.8,GO:0006468,protein phosphorylation,M1,1,0
1,-2.3,GO:2001259,positive regulation of cation channel activity,M1,1,0
1,-2.6,GO:1904950,negative regulation of establishment of protein localization,M1,1,0
1,-4.9,GO:0050819,negative regulation of coagulation,M1,1,0
1,-2.1,GO:0050435,amyloid-beta metabolic process,M1,1,0
1,-4.8,GO:0048545,response to steroid hormone,M1,1,0
1,-3.7,GO:0042552,myelination,M1,1,0
1,-2,GO:0001961,positive regulation of cytokine-mediated signaling pathway,M1,1,0
1,-2.7,hsa05146,Amoebiasis,M1,1,0
1,-4,GO:0071407,cellular response to organic cyclic compound,M1,1,0
1,-4.6,GO:0008544,epidermis development,M1,1,0
1,-4.9,GO:0045785,positive regulation of cell adhesion,M1,1,0
1,-2.5,GO:0051259,protein complex oligomerization,M1,1,0
1,-3.7,GO:0036438,maintenance of lens transparency,M1,1,0
1,-4,R-HSA-76002,"Platelet activation, signaling and aggregation",M1,1,0
1,-2.4,M255,PID HIF1 TFPATHWAY,M1,1,0
1,-2.6,GO:0014857,regulation of skeletal muscle cell proliferation,M1,1,0
1,-3.7,GO:1902743,regulation of lamellipodium organization,M1,1,0
1,-2.4,GO:0008277,regulation of G protein-coupled receptor signaling pathway,M1,1,0
1,-11,GO:0051272,positive regulation of cellular component movement,M1,1,0
1,-2.8,GO:0007422,peripheral nervous system development,M1,1,0
1,-3.3,GO:0042886,amide transport,M1,1,0
1,-2.3,GO:0034614,cellular response to reactive oxygen species,M1,1,0
1,-3.7,GO:2000463,positive regulation of excitatory postsynaptic potential,M1,1,0
1,-3.1,GO:0089718,amino acid import across plasma membrane,M1,1,0
1,-3.2,GO:0006681,galactosylceramide metabolic process,M1,1,0
1,-4.9,R-HSA-372790,Signaling by GPCR,M1,1,0
1,-5.1,GO:0071363,cellular response to growth factor stimulus,M1,1,0
1,-8.8,GO:0003018,vascular process in circulatory system,M1,1,0
1,-3.6,GO:0104004,cellular response to environmental stimulus,M1,1,0
1,-2.5,GO:0030832,regulation of actin filament length,M1,1,0
1,-2.3,GO:0003205,cardiac chamber development,M1,1,0
1,-3.7,GO:0007162,negative regulation of cell adhesion,M1,1,0
1,-5,GO:0046618,xenobiotic export,M1,1,0
1,-3.1,GO:0007218,neuropeptide signaling pathway,M1,1,0
1,-2.5,GO:0030856,regulation of epithelial cell differentiation,M1,1,0
1,-2.7,GO:0046835,carbohydrate phosphorylation,M1,1,0
1,-2.2,R-HSA-5602498,MyD88 deficiency (TLR2/4),M1,1,0
1,-4.2,GO:0043409,negative regulation of MAPK cascade,M1,1,0
1,-5.2,GO:0010975,regulation of neuron projection development,M1,1,0
1,-6.2,GO:0046486,glycerolipid metabolic process,M1,1,0
1,-2.3,R-HSA-5602358,Diseases associated with the TLR signaling cascade,M1,1,0
1,-2.2,GO:0001701,in utero embryonic development,M1,1,0
1,-2.3,GO:0072176,nephric duct development,M1,1,0
1,-5.1,GO:0070848,response to growth factor,M1,1,0
1,-2.3,hsa00520,Amino sugar and nucleotide sugar metabolism,M1,1,0
1,-3.1,GO:0030643,cellular phosphate ion homeostasis,M1,1,0
1,-3.2,GO:0043068,positive regulation of programmed cell death,M1,1,0
1,-2.4,hsa05145,Toxoplasmosis,M1,1,0
1,-2.7,GO:0050820,positive regulation of coagulation,M1,1,0
1,-8,GO:0015849,organic acid transport,M1,1,0
1,-4.1,GO:0061318,renal filtration cell differentiation,M1,1,0
1,-2,R-HSA-114608,Platelet degranulation,M1,1,0
1,-11,GO:0031344,regulation of cell projection organization,M1,1,0
1,-2.8,GO:0042330,taxis,M1,1,0
1,-2.3,GO:0071345,cellular response to cytokine stimulus,M1,1,0
1,-2.4,hsa00603,Glycosphingolipid biosynthesis - globo and isoglobo series,M1,1,0
1,-3,GO:0071559,response to transforming growth factor beta,M1,1,0
1,-2.4,GO:0001843,neural tube closure,M1,1,0
1,-2.7,GO:0030148,sphingolipid biosynthetic process,M1,1,0
1,-2.7,GO:0090023,positive regulation of neutrophil chemotaxis,M1,1,0
1,-5.4,GO:0031346,positive regulation of cell projection organization,M1,1,0
1,-5.8,hsa04015,Rap1 signaling pathway,M1,1,0
1,-5.7,GO:0034329,cell junction assembly,M1,1,0
1,-2.7,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,M1,1,0
1,-3.6,GO:0030111,regulation of Wnt signaling pathway,M1,1,0
1,-4.6,GO:0046683,response to organophosphorus,M1,1,0
1,-5.7,GO:0050804,modulation of chemical synaptic transmission,M1,1,0
1,-6.3,GO:0150104,transport across blood-brain barrier,M1,1,0
1,-12,GO:0055080,cation homeostasis,M1,1,0
1,-2,GO:0061572,actin filament bundle organization,M1,1,0
1,-5.4,GO:0001952,regulation of cell-matrix adhesion,M1,1,0
1,-5.7,GO:0071622,regulation of granulocyte chemotaxis,M1,1,0
1,-2.7,GO:1905521,regulation of macrophage migration,M1,1,0
1,-2.6,GO:0070839,metal ion export,M1,1,0
1,-3.6,GO:2000116,regulation of cysteine-type endopeptidase activity,M1,1,0
1,-3.4,GO:0015838,amino-acid betaine transport,M1,1,0
1,-2.1,GO:0032026,response to magnesium ion,M1,1,0
1,-2.4,hsa05417,Lipid and atherosclerosis,M1,1,0
1,-8,R-HSA-109582,Hemostasis,M1,1,0
1,-2.3,GO:0043403,skeletal muscle tissue regeneration,M1,1,0
1,-2.2,GO:0042326,negative regulation of phosphorylation,M1,1,0
1,-2.2,GO:0015718,monocarboxylic acid transport,M1,1,0
1,-2.4,GO:0010453,regulation of cell fate commitment,M1,1,0
1,-3.2,hsa04610,Complement and coagulation cascades,M1,1,0
1,-5.2,R-HSA-556833,Metabolism of lipids,M1,1,0
1,-4.2,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,M1,1,0
1,-2.3,R-HSA-397014,Muscle contraction,M1,1,0
1,-2.1,GO:0097435,supramolecular fiber organization,M1,1,0
1,-6,GO:0008217,regulation of blood pressure,M1,1,0
1,-2.1,R-HSA-936964,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,M1,1,0
1,-2.3,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,M1,1,0
1,-2.4,GO:0043032,positive regulation of macrophage activation,M1,1,0
1,-2.4,GO:0030307,positive regulation of cell growth,M1,1,0
1,-2.4,GO:1900076,regulation of cellular response to insulin stimulus,M1,1,0
1,-2.7,GO:0032966,negative regulation of collagen biosynthetic process,M1,1,0
1,-2.5,GO:0062208,positive regulation of pattern recognition receptor signaling pathway,M1,1,0
1,-3,GO:0060828,regulation of canonical Wnt signaling pathway,M1,1,0
1,-2.9,GO:0071385,cellular response to glucocorticoid stimulus,M1,1,0
1,-3.8,GO:0009117,nucleotide metabolic process,M1,1,0
1,-3.5,GO:0051480,regulation of cytosolic calcium ion concentration,M1,1,0
1,-2.8,GO:0022407,regulation of cell-cell adhesion,M1,1,0
1,-2.9,GO:0070391,response to lipoteichoic acid,M1,1,0
1,-2.9,GO:0007265,Ras protein signal transduction,M1,1,0
1,-2,GO:0009165,nucleotide biosynthetic process,M1,1,0
1,-4.7,GO:0046467,membrane lipid biosynthetic process,M1,1,0
1,-3.3,GO:0010665,regulation of cardiac muscle cell apoptotic process,M1,1,0
1,-3.7,GO:0022604,regulation of cell morphogenesis,M1,1,0
1,-2,GO:0042053,regulation of dopamine metabolic process,M1,1,0
1,-3.5,GO:0070085,glycosylation,M1,1,0
1,-2.7,WP4754,IL-18 signaling pathway,M1,1,0
1,-4.4,R-HSA-2672351,Stimuli-sensing channels,M1,1,0
1,-2.2,GO:0061564,axon development,M1,1,0
1,-2.6,GO:0035810,positive regulation of urine volume,M1,1,0
1,-2.3,R-HSA-975163,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,M1,1,0
1,-7.6,GO:0006814,sodium ion transport,M1,1,0
1,-4.6,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,M1,1,0
1,-3.2,R-HSA-6798695,Neutrophil degranulation,M1,1,0
1,-7.4,GO:0006874,cellular calcium ion homeostasis,M1,1,0
1,-3.9,GO:0009410,response to xenobiotic stimulus,M1,1,0
1,-3.6,GO:0046661,male sex differentiation,M1,1,0
1,-3.3,GO:0060070,canonical Wnt signaling pathway,M1,1,0
1,-3.8,GO:0032536,regulation of cell projection size,M1,1,0
1,-3.1,GO:0006898,receptor-mediated endocytosis,M1,1,0
1,-2.6,GO:0046718,viral entry into host cell,M1,1,0
1,-2.5,GO:0045995,regulation of embryonic development,M1,1,0
1,-2.5,GO:0032306,regulation of prostaglandin secretion,M1,1,0
1,-2.9,GO:0031663,lipopolysaccharide-mediated signaling pathway,M1,1,0
1,-2.9,GO:0035637,multicellular organismal signaling,M1,1,0
1,-5.9,GO:0071396,cellular response to lipid,M1,1,0
1,-3.2,GO:0045682,regulation of epidermis development,M1,1,0
1,-2.4,WP4534,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms,M1,1,0
1,-9.8,GO:0030335,positive regulation of cell migration,M1,1,0
1,-2.4,R-HSA-1474290,Collagen formation,M1,1,0
1,-2.6,R-HSA-112316,Neuronal System,M1,1,0
1,-4.3,GO:0007599,hemostasis,M1,1,0
1,-7.7,GO:0051347,positive regulation of transferase activity,M1,1,0
1,-3.1,GO:0120039,plasma membrane bounded cell projection morphogenesis,M1,1,0
1,-2.4,hsa05410,Hypertrophic cardiomyopathy,M1,1,0
1,-6.1,WP306,Focal adhesion,M1,1,0
1,-4.4,GO:0120032,regulation of plasma membrane bounded cell projection assembly,M1,1,0
1,-5.1,GO:1900047,negative regulation of hemostasis,M1,1,0
1,-2.9,GO:0008406,gonad development,M1,1,0
1,-2,GO:0046627,negative regulation of insulin receptor signaling pathway,M1,1,0
1,-3.1,GO:0034142,toll-like receptor 4 signaling pathway,M1,1,0
1,-3,GO:1904427,positive regulation of calcium ion transmembrane transport,M1,1,0
1,-2.1,GO:0001841,neural tube formation,M1,1,0
1,-3.1,GO:0010544,negative regulation of platelet activation,M1,1,0
1,-2.9,GO:0010766,negative regulation of sodium ion transport,M1,1,0
1,-3.5,GO:0006865,amino acid transport,M1,1,0
1,-5.9,GO:0048608,reproductive structure development,M1,1,0
1,-4.5,GO:2000027,regulation of animal organ morphogenesis,M1,1,0
1,-2.7,GO:0090331,negative regulation of platelet aggregation,M1,1,0
1,-4.6,GO:0009247,glycolipid biosynthetic process,M1,1,0
1,-2.5,GO:0060760,positive regulation of response to cytokine stimulus,M1,1,0
1,-3.6,WP2272,Pathogenic Escherichia coli infection,M1,1,0
1,-2.1,GO:0072202,cell differentiation involved in metanephros development,M1,1,0
1,-2.5,GO:0009116,nucleoside metabolic process,M1,1,0
1,-2.9,hsa04010,MAPK signaling pathway,M1,1,0
1,-2.3,GO:0042445,hormone metabolic process,M1,1,0
1,-2.4,hsa04915,Estrogen signaling pathway,M1,1,0
1,-3.5,GO:0051898,negative regulation of protein kinase B signaling,M1,1,0
1,-7.9,GO:0042391,regulation of membrane potential,M1,1,0
1,-5.3,GO:0050807,regulation of synapse organization,M1,1,0
1,-8.6,GO:0030193,regulation of blood coagulation,M1,1,0
1,-2.5,GO:2001235,positive regulation of apoptotic signaling pathway,M1,1,0
1,-4.7,GO:0071902,positive regulation of protein serine/threonine kinase activity,M1,1,0
1,-5.5,hsa04510,Focal adhesion,M1,1,0
1,-3.6,GO:0007229,integrin-mediated signaling pathway,M1,1,0
1,-3.7,WP3925,Amino acid metabolism,M1,1,0
1,-2.1,GO:0019226,transmission of nerve impulse,M1,1,0
1,-3.2,GO:0042542,response to hydrogen peroxide,M1,1,0
1,-4.4,GO:0043062,extracellular structure organization,M1,1,0
1,-2.8,GO:0099003,vesicle-mediated transport in synapse,M1,1,0
1,-2,GO:0018208,peptidyl-proline modification,M1,1,0
1,-5.4,GO:0140115,export across plasma membrane,M1,1,0
1,-2.5,GO:0006767,water-soluble vitamin metabolic process,M1,1,0
1,-4.1,GO:0061138,morphogenesis of a branching epithelium,M1,1,0
1,-10,GO:0120035,regulation of plasma membrane bounded cell projection organization,M1,1,0
1,-5.7,GO:0006940,regulation of smooth muscle contraction,M1,1,0
1,-2.3,GO:0051924,regulation of calcium ion transport,M1,1,0
1,-5.2,R-HSA-3000171,Non-integrin membrane-ECM interactions,M1,1,0
1,-9.7,GO:0072001,renal system development,M1,1,0
1,-2,GO:0031998,regulation of fatty acid beta-oxidation,M1,1,0
1,-2.2,GO:0090596,sensory organ morphogenesis,M1,1,0
1,-2.4,M239,PID A6B1 A6B4 INTEGRIN PATHWAY,M1,1,0
1,-2.8,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),M1,1,0
1,-4.3,GO:0048732,gland development,M1,1,0
1,-2.6,GO:0002833,positive regulation of response to biotic stimulus,M1,1,0
1,-2.7,GO:0050891,multicellular organismal water homeostasis,M1,1,0
1,-4,GO:0098609,cell-cell adhesion,M1,1,0
1,-3.3,GO:0048639,positive regulation of developmental growth,M1,1,0
1,-2.7,GO:0045604,regulation of epidermal cell differentiation,M1,1,0
1,-3.8,GO:0070374,positive regulation of ERK1 and ERK2 cascade,M1,1,0
1,-3.9,GO:0015698,inorganic anion transport,M1,1,0
1,-2.6,GO:0014075,response to amine,M1,1,0
1,-2.4,GO:0009395,phospholipid catabolic process,M1,1,0
1,-5.6,GO:0031667,response to nutrient levels,M1,1,0
1,-3,GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,M1,1,0
1,-4.3,GO:0048754,branching morphogenesis of an epithelial tube,M1,1,0
1,-2,GO:0043586,tongue development,M1,1,0
1,-2.4,hsa04930,Type II diabetes mellitus,M1,1,0
1,-4,GO:0051271,negative regulation of cellular component movement,M1,1,0
1,-2.5,hsa00601,Glycosphingolipid biosynthesis - lacto and neolacto series,M1,1,0
1,-4.4,GO:0032496,response to lipopolysaccharide,M1,1,0
1,-3.4,GO:0090330,regulation of platelet aggregation,M1,1,0
1,-2.3,GO:0048013,ephrin receptor signaling pathway,M1,1,0
1,-2.5,GO:0009063,cellular amino acid catabolic process,M1,1,0
1,-3,hsa00330,Arginine and proline metabolism,M1,1,0
1,-4.1,GO:0015695,organic cation transport,M1,1,0
1,-4.1,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),M1,1,0
1,-6.4,GO:0034764,positive regulation of transmembrane transport,M1,1,0
1,-4.1,GO:0001656,metanephros development,M1,1,0
1,-4.4,GO:0007272,ensheathment of neurons,M1,1,0
1,-5.2,GO:1904064,positive regulation of cation transmembrane transport,M1,1,0
1,-4.6,GO:0043588,skin development,M1,1,0
1,-2,GO:0032963,collagen metabolic process,M1,1,0
1,-6.7,GO:0034767,positive regulation of ion transmembrane transport,M1,1,0
1,-2.2,GO:2000191,regulation of fatty acid transport,M1,1,0
1,-2.7,GO:0042472,inner ear morphogenesis,M1,1,0
1,-6.1,GO:0008654,phospholipid biosynthetic process,M1,1,0
1,-8.1,GO:0090407,organophosphate biosynthetic process,M1,1,0
1,-7.1,GO:0045216,cell-cell junction organization,M1,1,0
1,-7.6,GO:0051051,negative regulation of transport,M1,1,0
1,-3.6,GO:0070482,response to oxygen levels,M1,1,0
1,-4.1,GO:0003382,epithelial cell morphogenesis,M1,1,0
1,-4.6,R-HSA-3000170,Syndecan interactions,M1,1,0
1,-3.1,WP4018,Clear cell renal cell carcinoma pathways,M1,1,0
1,-2.6,R-HSA-1483213,Synthesis of PE,M1,1,0
1,-2.3,GO:0034311,diol metabolic process,M1,1,0
1,-2.8,GO:0060113,inner ear receptor cell differentiation,M1,1,0
1,-3.9,GO:1902745,positive regulation of lamellipodium organization,M1,1,0
1,-3.4,GO:1901136,carbohydrate derivative catabolic process,M1,1,0
1,-2.4,GO:0006677,glycosylceramide metabolic process,M1,1,0
1,-2.7,GO:0051223,regulation of protein transport,M1,1,0
1,-2.4,GO:0019511,peptidyl-proline hydroxylation,M1,1,0
1,-4.2,GO:0035813,regulation of renal sodium excretion,M1,1,0
1,-3.8,GO:0046434,organophosphate catabolic process,M1,1,0
1,-3.5,GO:0001977,renal system process involved in regulation of blood volume,M1,1,0
1,-9,GO:0033674,positive regulation of kinase activity,M1,1,0
1,-4.4,GO:0061061,muscle structure development,M1,1,0
1,-2.7,GO:0099643,signal release from synapse,M1,1,0
1,-2.3,WP4971,Phosphoinositides metabolism,M1,1,0
1,-6.2,GO:0098657,import into cell,M1,1,0
1,-2.6,GO:0034143,regulation of toll-like receptor 4 signaling pathway,M1,1,0
1,-2.8,GO:0034145,positive regulation of toll-like receptor 4 signaling pathway,M1,1,0
1,-3.6,GO:0001819,positive regulation of cytokine production,M1,1,0
1,-2.3,GO:0030326,embryonic limb morphogenesis,M1,1,0
1,-2.2,GO:0007519,skeletal muscle tissue development,M1,1,0
1,-3.2,GO:0050708,regulation of protein secretion,M1,1,0
1,-2.7,GO:0010469,regulation of signaling receptor activity,M1,1,0
1,-2.7,GO:1904350,regulation of protein catabolic process in the vacuole,M1,1,0
1,-2.8,GO:0055081,anion homeostasis,M1,1,0
1,-3.8,hsa05230,Central carbon metabolism in cancer,M1,1,0
1,-4.3,GO:0001666,response to hypoxia,M1,1,0
1,-3.5,GO:0035904,aorta development,M1,1,0
1,-5.1,GO:0045446,endothelial cell differentiation,M1,1,0
1,-2.2,GO:0033875,ribonucleoside bisphosphate metabolic process,M1,1,0
1,-2.1,GO:0006882,cellular zinc ion homeostasis,M1,1,0
1,-3.2,GO:2000378,negative regulation of reactive oxygen species metabolic process,M1,1,0
1,-3.2,GO:2000106,regulation of leukocyte apoptotic process,M1,1,0
1,-2.7,GO:0014842,regulation of skeletal muscle satellite cell proliferation,M1,1,0
1,-3.4,GO:0046888,negative regulation of hormone secretion,M1,1,0
1,-3.3,hsa04974,Protein digestion and absorption,M1,1,0
1,-3.7,GO:0048791,calcium ion-regulated exocytosis of neurotransmitter,M1,1,0
1,-2.2,GO:0140056,organelle localization by membrane tethering,M1,1,0
1,-4.8,GO:0051056,regulation of small GTPase mediated signal transduction,M1,1,0
1,-4,GO:0006972,hyperosmotic response,M1,1,0
1,-2.6,GO:0009259,ribonucleotide metabolic process,M1,1,0
1,-2.2,GO:0048534,hematopoietic or lymphoid organ development,M1,1,0
1,-3,GO:0009064,glutamine family amino acid metabolic process,M1,1,0
1,-3.2,GO:0044283,small molecule biosynthetic process,M1,1,0
1,-2.5,GO:0090504,epiboly,M1,1,0
1,-2.5,GO:0003015,heart process,M1,1,0
1,-3.4,GO:0000052,citrulline metabolic process,M1,1,0
1,-4.6,WP3932,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,M1,1,0
1,-2.2,WP1946,Cori cycle,M1,1,0
1,-2.1,GO:0006044,N-acetylglucosamine metabolic process,M1,1,0
1,-2.3,hsa05017,Spinocerebellar ataxia,M1,1,0
1,-2.6,GO:0072164,mesonephric tubule development,M1,1,0
1,-2.4,GO:0006835,dicarboxylic acid transport,M1,1,0
1,-2.1,GO:0051493,regulation of cytoskeleton organization,M1,1,0
1,-5.9,GO:0009991,response to extracellular stimulus,M1,1,0
1,-2.1,hsa04972,Pancreatic secretion,M1,1,0
1,-2.2,GO:0015909,long-chain fatty acid transport,M1,1,0
1,-10,GO:0002064,epithelial cell development,M1,1,0
1,-2.3,R-HSA-3781865,Diseases of glycosylation,M1,1,0
1,-4.5,GO:1903035,negative regulation of response to wounding,M1,1,0
1,-2.7,GO:2001233,regulation of apoptotic signaling pathway,M1,1,0
1,-2.3,GO:2000095,"regulation of Wnt signaling pathway, planar cell polarity pathway",M1,1,0
1,-3.7,GO:0098754,detoxification,M1,1,0
1,-8.5,GO:0001934,positive regulation of protein phosphorylation,M1,1,0
1,-2.4,GO:0045600,positive regulation of fat cell differentiation,M1,1,0
1,-3.1,GO:0006665,sphingolipid metabolic process,M1,1,0
1,-2.4,R-HSA-1660662,Glycosphingolipid metabolism,M1,1,0
1,-5.3,WP1424,Globo sphingolipid metabolism,M1,1,0
1,-2.1,GO:0051453,regulation of intracellular pH,M1,1,0
1,-3.8,hsa04024,cAMP signaling pathway,M1,1,0
1,-4.2,GO:0045933,positive regulation of muscle contraction,M1,1,0
1,-3.1,GO:0051930,regulation of sensory perception of pain,M1,1,0
1,-3.2,R-HSA-9012999,RHO GTPase cycle,M1,1,0
1,-7.8,R-HSA-425407,SLC-mediated transmembrane transport,M1,1,0
1,-3.4,GO:1903531,negative regulation of secretion by cell,M1,1,0
1,-2.5,GO:0010460,positive regulation of heart rate,M1,1,0
1,-2,GO:1902074,response to salt,M1,1,0
1,-4.9,GO:1903825,organic acid transmembrane transport,M1,1,0
1,-2.1,R-HSA-442660,Na+/Cl- dependent neurotransmitter transporters,M1,1,0
1,-3.4,GO:0070633,transepithelial transport,M1,1,0
1,-2.7,GO:0043090,amino acid import,M1,1,0
1,-7,GO:0010543,regulation of platelet activation,M1,1,0
1,-2.1,GO:0072080,nephron tubule development,M1,1,0
1,-2.4,GO:0051235,maintenance of location,M1,1,0
1,-3.5,GO:0071548,response to dexamethasone,M1,1,0
1,-2.4,GO:1904424,regulation of GTP binding,M1,1,0
1,-2.2,GO:0032956,regulation of actin cytoskeleton organization,M1,1,0
1,-11,GO:0030003,cellular cation homeostasis,M1,1,0
1,-5.1,GO:0001763,morphogenesis of a branching structure,M1,1,0
1,-2.1,hsa01521,EGFR tyrosine kinase inhibitor resistance,M1,1,0
1,-3.4,GO:0035296,regulation of tube diameter,M1,1,0
1,-2.9,GO:0043009,chordate embryonic development,M1,1,0
1,-2,GO:0046777,protein autophosphorylation,M1,1,0
1,-2.9,GO:0034763,negative regulation of transmembrane transport,M1,1,0
1,-6.3,R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",M1,1,0
1,-2.2,GO:0034308,primary alcohol metabolic process,M1,1,0
1,-9.6,GO:0098655,cation transmembrane transport,M1,1,0
1,-3.1,GO:0051931,regulation of sensory perception,M1,1,0
1,-3.3,hsa04080,Neuroactive ligand-receptor interaction,M1,1,0
1,-3.2,GO:0070302,regulation of stress-activated protein kinase signaling cascade,M1,1,0
1,-4.7,GO:0032989,cellular component morphogenesis,M1,1,0
1,-2.8,GO:1900077,negative regulation of cellular response to insulin stimulus,M1,1,0
1,-2.6,GO:0003231,cardiac ventricle development,M1,1,0
1,-2.7,GO:0009755,hormone-mediated signaling pathway,M1,1,0
1,-4.9,hsa00564,Glycerophospholipid metabolism,M1,1,0
1,-2,hsa04960,Aldosterone-regulated sodium reabsorption,M1,1,0
1,-2.1,GO:0046473,phosphatidic acid metabolic process,M1,1,0
1,-2.5,GO:0007205,protein kinase C-activating G protein-coupled receptor signaling pathway,M1,1,0
1,-3.2,GO:0062207,regulation of pattern recognition receptor signaling pathway,M1,1,0
1,-3.9,GO:0043434,response to peptide hormone,M1,1,0
1,-4,WP4541,Hippo-Merlin signaling dysregulation,M1,1,0
1,-5.4,GO:0007423,sensory organ development,M1,1,0
1,-5.4,GO:0048514,blood vessel morphogenesis,M1,1,0
1,-2.3,GO:0046475,glycerophospholipid catabolic process,M1,1,0
1,-2.7,GO:0001953,negative regulation of cell-matrix adhesion,M1,1,0
1,-2.2,GO:0086004,regulation of cardiac muscle cell contraction,M1,1,0
1,-2.8,GO:0035966,response to topologically incorrect protein,M1,1,0
1,-3.4,GO:0006986,response to unfolded protein,M1,1,0
1,-3.4,GO:0034656,nucleobase-containing small molecule catabolic process,M1,1,0
1,-6.2,GO:0044282,small molecule catabolic process,M1,1,0
1,-5.9,GO:0072073,kidney epithelium development,M1,1,0
1,-2.6,GO:0045936,negative regulation of phosphate metabolic process,M1,1,0
1,-4.5,GO:0006970,response to osmotic stress,M1,1,0
1,-2.1,GO:0050767,regulation of neurogenesis,M1,1,0
1,-2.9,GO:0045056,transcytosis,M1,1,0
1,-3.5,GO:0015697,quaternary ammonium group transport,M1,1,0
1,-3.3,GO:0048667,cell morphogenesis involved in neuron differentiation,M1,1,0
1,-3.1,hsa00600,Sphingolipid metabolism,M1,1,0
1,-3.6,GO:0031960,response to corticosteroid,M1,1,0
1,-5,GO:0060322,head development,M1,1,0
1,-2.9,GO:0035809,regulation of urine volume,M1,1,0
1,-2.6,GO:0072163,mesonephric epithelium development,M1,1,0
1,-2.2,GO:0032755,positive regulation of interleukin-6 production,M1,1,0
1,-2.4,hsa04668,TNF signaling pathway,M1,1,0
1,-2.3,GO:0006505,GPI anchor metabolic process,M1,1,0
1,-2.8,GO:1900048,positive regulation of hemostasis,M1,1,0
1,-2.1,GO:0015936,coenzyme A metabolic process,M1,1,0
1,-2.3,GO:0044106,cellular amine metabolic process,M1,1,0
1,-4.5,hsa04072,Phospholipase D signaling pathway,M1,1,0
1,-5,GO:0003073,regulation of systemic arterial blood pressure,M1,1,0
1,-2.2,GO:0007033,vacuole organization,M1,1,0
1,-2,GO:0003176,aortic valve development,M1,1,0
1,-4.2,GO:0048638,regulation of developmental growth,M1,1,0
1,-2.4,GO:0033628,regulation of cell adhesion mediated by integrin,M1,1,0
1,-2,GO:0030514,negative regulation of BMP signaling pathway,M1,1,0
1,-3.1,GO:0035461,vitamin transmembrane transport,M1,1,0
1,-3.9,GO:0006486,protein glycosylation,M1,1,0
1,-2.5,WP5121,Sphingolipid metabolism in senescence,M1,1,0
1,-4.3,GO:0045861,negative regulation of proteolysis,M1,1,0
1,-2.3,GO:0006163,purine nucleotide metabolic process,M1,1,0
1,-2.2,GO:0051701,biological process involved in interaction with host,M1,1,0
1,-2.3,GO:0016055,Wnt signaling pathway,M1,1,0
1,-3,R-HSA-5173105,O-linked glycosylation,M1,1,0
1,-3.1,GO:0042538,hyperosmotic salinity response,M1,1,0
1,-2.4,GO:0007405,neuroblast proliferation,M1,1,0
1,-2.1,R-HSA-5683057,MAPK family signaling cascades,M1,1,0
1,-6.9,GO:0002028,regulation of sodium ion transport,M1,1,0
1,-2.6,GO:0097305,response to alcohol,M1,1,0
1,-9.1,GO:0001655,urogenital system development,M1,1,0
1,-2.5,GO:0010592,positive regulation of lamellipodium assembly,M1,1,0
1,-2.2,GO:0031347,regulation of defense response,M1,1,0
1,-9.7,GO:0043408,regulation of MAPK cascade,M1,1,0
1,-6.8,GO:0001944,vasculature development,M1,1,0
1,-4.3,GO:0014074,response to purine-containing compound,M1,1,0
1,-2.8,GO:0016079,synaptic vesicle exocytosis,M1,1,0
1,-2.2,GO:0060292,long-term synaptic depression,M1,1,0
1,-3,GO:0060284,regulation of cell development,M1,1,0
1,-2.7,GO:0007269,neurotransmitter secretion,M1,1,0
1,-2.2,GO:0009308,amine metabolic process,M1,1,0
1,-2.3,GO:0090090,negative regulation of canonical Wnt signaling pathway,M1,1,0
1,-2.8,GO:0060840,artery development,M1,1,0
1,-3.5,GO:0046328,regulation of JNK cascade,M1,1,0
1,-11,GO:0042060,wound healing,M1,1,0
1,-2.9,R-HSA-5083635,Defective B3GALTL causes PpS,M1,1,0
1,-5,GO:0032757,positive regulation of interleukin-8 production,M1,1,0
1,-7.7,GO:0035239,tube morphogenesis,M1,1,0
1,-4.3,GO:1903532,positive regulation of secretion by cell,M1,1,0
1,-4,GO:0002237,response to molecule of bacterial origin,M1,1,0
1,-3.3,R-HSA-140534,Caspase activation via Death Receptors in the presence of ligand,M1,1,0
1,-6.4,GO:0002009,morphogenesis of an epithelium,M1,1,0
1,-3.8,GO:0035815,positive regulation of renal sodium excretion,M1,1,0
1,-4.8,GO:0016054,organic acid catabolic process,M1,1,0
1,-5.1,GO:0040008,regulation of growth,M1,1,0
1,-2.6,hsa04064,NF-kappa B signaling pathway,M1,1,0
1,-2.2,WP4549,Fragile X syndrome,M1,1,0
1,-3.1,GO:0019216,regulation of lipid metabolic process,M1,1,0
1,-4.9,GO:0035850,epithelial cell differentiation involved in kidney development,M1,1,0
1,-2.1,GO:0071398,cellular response to fatty acid,M1,1,0
1,-2.1,GO:1905207,regulation of cardiocyte differentiation,M1,1,0
1,-4.2,WP98,Prostaglandin synthesis and regulation,M1,1,0
1,-3,GO:0015908,fatty acid transport,M1,1,0
1,-2.9,GO:0009119,ribonucleoside metabolic process,M1,1,0
1,-2.1,GO:0010638,positive regulation of organelle organization,M1,1,0
1,-3,GO:0048858,cell projection morphogenesis,M1,1,0
1,-2.7,GO:0032490,detection of molecule of bacterial origin,M1,1,0
1,-2.6,GO:0090505,epiboly involved in wound healing,M1,1,0
1,-3.6,GO:0032868,response to insulin,M1,1,0
1,-2.9,GO:0035907,dorsal aorta development,M1,1,0
1,-4.4,GO:0050817,coagulation,M1,1,0
1,-2.2,M44,PID HIF2PATHWAY,M1,1,0
1,-3.3,M83,PID CDC42 REG PATHWAY,M1,1,0
1,-2.3,GO:0198738,cell-cell signaling by wnt,M1,1,0
1,-2.1,R-HSA-446193,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",M1,1,0
1,-5.3,GO:0051047,positive regulation of secretion,M1,1,0
1,-2.7,GO:0051224,negative regulation of protein transport,M1,1,0
1,-4,GO:0072311,glomerular epithelial cell differentiation,M1,1,0
1,-2.2,GO:0032869,cellular response to insulin stimulus,M1,1,0
1,-5,GO:1901184,regulation of ERBB signaling pathway,M1,1,0
1,-3.7,GO:0061097,regulation of protein tyrosine kinase activity,M1,1,0
1,-3.5,GO:0098916,anterograde trans-synaptic signaling,M1,1,0
1,-10,GO:0009725,response to hormone,M1,1,0
1,-2.2,GO:0030048,actin filament-based movement,M1,1,0
1,-2.8,GO:0072521,purine-containing compound metabolic process,M1,1,0
1,-3,GO:1901658,glycosyl compound catabolic process,M1,1,0
1,-2,GO:0042069,regulation of catecholamine metabolic process,M1,1,0
1,-2.2,GO:0048015,phosphatidylinositol-mediated signaling,M1,1,0
1,-2.2,R-HSA-112310,Neurotransmitter release cycle,M1,1,0
1,-4.1,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,M1,1,0
1,-6.8,GO:0032412,regulation of ion transmembrane transporter activity,M1,1,0
1,-2.5,GO:0048148,behavioral response to cocaine,M1,1,0
1,-2.3,GO:0045986,negative regulation of smooth muscle contraction,M1,1,0
1,-6.6,GO:0043087,regulation of GTPase activity,M1,1,0
1,-5.2,GO:0042246,tissue regeneration,M1,1,0
1,-4.7,R-HSA-388396,GPCR downstream signalling,M1,1,0
1,-8.6,GO:0001822,kidney development,M1,1,0
1,-2.1,WP5052,Nephrogenesis,M1,1,0
1,-2.1,R-HSA-5603041,IRAK4 deficiency (TLR2/4),M1,1,0
1,-2.1,GO:0002791,regulation of peptide secretion,M1,1,0
1,-2.5,GO:0042133,neurotransmitter metabolic process,M1,1,0
1,-4.1,GO:0008016,regulation of heart contraction,M1,1,0
1,-3.4,GO:0006766,vitamin metabolic process,M1,1,0
1,-4.6,GO:0044089,positive regulation of cellular component biogenesis,M1,1,0
1,-3,GO:0030100,regulation of endocytosis,M1,1,0
1,-2.1,hsa04971,Gastric acid secretion,M1,1,0
1,-4.7,GO:0030968,endoplasmic reticulum unfolded protein response,M1,1,0
1,-2.2,hsa05215,Prostate cancer,M1,1,0
1,-2.8,GO:0045598,regulation of fat cell differentiation,M1,1,0
1,-4.1,GO:0099536,synaptic signaling,M1,1,0
1,-2.7,GO:0030178,negative regulation of Wnt signaling pathway,M1,1,0
1,-3.2,GO:0071560,cellular response to transforming growth factor beta stimulus,M1,1,0
1,-2.3,GO:0051209,release of sequestered calcium ion into cytosol,M1,1,0
1,-3.7,R-HSA-446728,Cell junction organization,M1,1,0
1,-5.3,GO:0042058,regulation of epidermal growth factor receptor signaling pathway,M1,1,0
1,-2,GO:0014821,phasic smooth muscle contraction,M1,1,0
1,-2.8,GO:0043954,cellular component maintenance,M1,1,0
1,-2,GO:0009150,purine ribonucleotide metabolic process,M1,1,0
1,-5.2,GO:0060249,anatomical structure homeostasis,M1,1,0
1,-2.8,R-HSA-936837,Ion transport by P-type ATPases,M1,1,0
1,-2.4,hsa04724,Glutamatergic synapse,M1,1,0
1,-2.7,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,M1,1,0
1,-4.3,GO:0006897,endocytosis,M1,1,0
1,-2.1,GO:0019751,polyol metabolic process,M1,1,0
1,-2.6,GO:0090200,positive regulation of release of cytochrome c from mitochondria,M1,1,0
1,-2.1,GO:0051017,actin filament bundle assembly,M1,1,0
1,-3.4,GO:1901654,response to ketone,M1,1,0
1,-2.4,GO:0060606,tube closure,M1,1,0
1,-2.6,GO:0010632,regulation of epithelial cell migration,M1,1,0
1,-2,GO:0034766,negative regulation of ion transmembrane transport,M1,1,0
1,-2,GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,M1,1,0
1,-2.6,GO:0044409,entry into host,M1,1,0
1,-2.7,GO:1905523,positive regulation of macrophage migration,M1,1,0
1,-2.5,hsa04911,Insulin secretion,M1,1,0
1,-2.5,GO:0040014,regulation of multicellular organism growth,M1,1,0
1,-3,WP2877,Vitamin D receptor pathway,M1,1,0
1,-5,GO:1901615,organic hydroxy compound metabolic process,M1,1,0
1,-2.3,GO:0006739,NADP metabolic process,M1,1,0
1,-2.5,GO:0070665,positive regulation of leukocyte proliferation,M1,1,0
1,-11,GO:0061041,regulation of wound healing,M1,1,0
1,-4.9,WP4172,PI3K-Akt signaling pathway,M1,1,0
1,-2.1,GO:0045777,positive regulation of blood pressure,M1,1,0
1,-2.6,R-HSA-75205,Dissolution of Fibrin Clot,M1,1,0
1,-4.4,GO:0043266,regulation of potassium ion transport,M1,1,0
1,-8.3,GO:0043549,regulation of kinase activity,M1,1,0
1,-3.7,GO:0072010,glomerular epithelium development,M1,1,0
1,-3.5,GO:0006687,glycosphingolipid metabolic process,M1,1,0
1,-7.3,GO:0051046,regulation of secretion,M1,1,0
1,-2,GO:0042733,embryonic digit morphogenesis,M1,1,0
1,-2.5,GO:0007015,actin filament organization,M1,1,0
1,-2.3,GO:2000107,negative regulation of leukocyte apoptotic process,M1,1,0
1,-3.2,GO:0007204,positive regulation of cytosolic calcium ion concentration,M1,1,0
1,-4.5,GO:0044070,regulation of anion transport,M1,1,0
1,-2.2,GO:0017157,regulation of exocytosis,M1,1,0
1,-5,GO:0061005,cell differentiation involved in kidney development,M1,1,0
1,-2.2,GO:0006672,ceramide metabolic process,M1,1,0
1,-2.2,M212,PID INTEGRIN5 PATHWAY,M1,1,0
1,-3.2,GO:0010759,positive regulation of macrophage chemotaxis,M1,1,0
1,-2.8,GO:0030866,cortical actin cytoskeleton organization,M1,1,0
1,-4.7,GO:0042908,xenobiotic transport,M1,1,0
1,-5,GO:0001885,endothelial cell development,M1,1,0
1,-4.1,GO:0050890,cognition,M1,1,0
1,-3.3,GO:0010927,cellular component assembly involved in morphogenesis,M1,1,0
1,-8.8,GO:0034762,regulation of transmembrane transport,M1,1,0
1,-2.6,M47,PID INTEGRIN CS PATHWAY,M1,1,0
1,-3.1,R-HSA-9013148,CDC42 GTPase cycle,M1,1,0
1,-2.2,hsa00562,Inositol phosphate metabolism,M1,1,0
1,-7.6,M3468,NABA ECM REGULATORS,M1,1,0
1,-2.8,GO:0098815,modulation of excitatory postsynaptic potential,M1,1,0
1,-7.3,GO:0052548,regulation of endopeptidase activity,M1,1,0
1,-4.3,GO:0042045,epithelial fluid transport,M1,1,0
1,-5.1,GO:0007264,small GTPase mediated signal transduction,M1,1,0
1,-5.5,GO:1903530,regulation of secretion by cell,M1,1,0
1,-2.4,GO:0015701,bicarbonate transport,M1,1,0
1,-2.4,GO:0099587,inorganic ion import across plasma membrane,M1,1,0
1,-2.1,GO:0010827,regulation of glucose transmembrane transport,M1,1,0
1,-5.8,GO:0048839,inner ear development,M1,1,0
1,-4.7,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,M1,1,0
1,-2.9,GO:1901653,cellular response to peptide,M1,1,0
1,-2.3,GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,M1,1,0
1,-2.8,GO:0006693,prostaglandin metabolic process,M1,1,0
1,-3,GO:0003333,amino acid transmembrane transport,M1,1,0
1,-4.8,GO:0030162,regulation of proteolysis,M1,1,0
1,-3.1,GO:0072502,cellular trivalent inorganic anion homeostasis,M1,1,0
1,-2.4,GO:0070301,cellular response to hydrogen peroxide,M1,1,0
1,-2.4,GO:2000052,positive regulation of non-canonical Wnt signaling pathway,M1,1,0
1,-15,GO:0050801,ion homeostasis,M1,1,0
1,-4.3,GO:0007548,sex differentiation,M1,1,0
1,-5.2,GO:0009100,glycoprotein metabolic process,M1,1,0
1,-3.8,R-HSA-1500931,Cell-Cell communication,M1,1,0
1,-3.1,GO:1901214,regulation of neuron death,M1,1,0
1,-3,GO:0021987,cerebral cortex development,M1,1,0
1,-3.7,GO:0009164,nucleoside catabolic process,M1,1,0
1,-2.7,GO:2000649,regulation of sodium ion transmembrane transporter activity,M1,1,0
1,-2.8,GO:0042594,response to starvation,M1,1,0
1,-3.6,GO:0009913,epidermal cell differentiation,M1,1,0
1,-2.8,GO:0043616,keratinocyte proliferation,M1,1,0
1,-2.1,GO:0090087,regulation of peptide transport,M1,1,0
1,-2.6,GO:0060395,SMAD protein signal transduction,M1,1,0
1,-3.1,GO:0007517,muscle organ development,M1,1,0
1,-2.7,GO:0010634,positive regulation of epithelial cell migration,M1,1,0
1,-3.1,GO:0010765,positive regulation of sodium ion transport,M1,1,0
1,-2.6,GO:0071549,cellular response to dexamethasone stimulus,M1,1,0
1,-2.5,GO:0032308,positive regulation of prostaglandin secretion,M1,1,0
1,-2.6,WP5053,Development of ureteric collection system,M1,1,0
1,-2.6,GO:0010563,negative regulation of phosphorus metabolic process,M1,1,0
1,-3.5,GO:0051384,response to glucocorticoid,M1,1,0
1,-2.4,GO:1901657,glycosyl compound metabolic process,M1,1,0
1,-4.7,GO:1901699,cellular response to nitrogen compound,M1,1,0
1,-3.8,R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,M1,1,0
1,-8.5,GO:0015711,organic anion transport,M1,1,0
1,-3.2,R-HSA-375276,Peptide ligand-binding receptors,M1,1,0
1,-4,WP2197,Endothelin pathways,M1,1,0
1,-3,GO:0006066,alcohol metabolic process,M1,1,0
1,-2.6,GO:0046883,regulation of hormone secretion,M1,1,0
1,-5.2,hsa04151,PI3K-Akt signaling pathway,M1,1,0
1,-2.3,GO:0035094,response to nicotine,M1,1,0
1,-5.6,GO:0050954,sensory perception of mechanical stimulus,M1,1,0
1,-3,GO:0050679,positive regulation of epithelial cell proliferation,M1,1,0
1,-2.5,GO:0032526,response to retinoic acid,M1,1,0
1,-5.5,GO:0072348,sulfur compound transport,M1,1,0
1,-2.3,GO:0045862,positive regulation of proteolysis,M1,1,0
1,-6.3,GO:0010232,vascular transport,M1,1,0
1,-3.1,GO:0040013,negative regulation of locomotion,M1,1,0
1,-8.6,GO:0043410,positive regulation of MAPK cascade,M1,1,0
1,-3.5,hsa04070,Phosphatidylinositol signaling system,M1,1,0
1,-3.5,GO:0034620,cellular response to unfolded protein,M1,1,0
1,-2.9,hsa04020,Calcium signaling pathway,M1,1,0
1,-2.4,GO:0110110,positive regulation of animal organ morphogenesis,M1,1,0
1,-2.5,R-HSA-194138,Signaling by VEGF,M1,1,0
1,-2.7,WP558,Complement and coagulation cascades,M1,1,0
1,-2.5,R-HSA-446219,Synthesis of substrates in N-glycan biosythesis,M1,1,0
1,-5.5,GO:0006650,glycerophospholipid metabolic process,M1,1,0
1,-3.8,GO:0032787,monocarboxylic acid metabolic process,M1,1,0
1,-2.4,GO:0090199,regulation of release of cytochrome c from mitochondria,M1,1,0
1,-2.1,GO:0007249,I-kappaB kinase/NF-kappaB signaling,M1,1,0
1,-2.2,R-HSA-5619102,SLC transporter disorders,M1,1,0
1,-3.2,GO:0030888,regulation of B cell proliferation,M1,1,0
1,-10,GO:0043269,regulation of ion transport,M1,1,0
1,-2.1,R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,M1,1,0
1,-4.8,GO:0098656,anion transmembrane transport,M1,1,0
1,-2.3,GO:0035113,embryonic appendage morphogenesis,M1,1,0
1,-9.4,GO:0006875,cellular metal ion homeostasis,M1,1,0
1,-2.2,GO:0022411,cellular component disassembly,M1,1,0
1,-3.3,GO:0010660,regulation of muscle cell apoptotic process,M1,1,0
1,-3.9,GO:0014902,myotube differentiation,M1,1,0
1,-2.7,WP4917,Proximal tubule transport,M1,1,0
1,-2.5,GO:0099170,postsynaptic modulation of chemical synaptic transmission,M1,1,0
1,-4.4,hsa04810,Regulation of actin cytoskeleton,M1,1,0
1,-3.9,GO:0009101,glycoprotein biosynthetic process,M1,1,0
1,-3.8,GO:0005975,carbohydrate metabolic process,M1,1,0
1,-2.2,GO:0006895,Golgi to endosome transport,M1,1,0
1,-2.7,GO:0038180,nerve growth factor signaling pathway,M1,1,0
1,-3.6,GO:0070588,calcium ion transmembrane transport,M1,1,0
1,-2.4,M5884,NABA CORE MATRISOME,M1,1,0
1,-3.1,GO:0019374,galactolipid metabolic process,M1,1,0
1,-3.3,GO:0019693,ribose phosphate metabolic process,M1,1,0
1,-2.8,GO:0001508,action potential,M1,1,0
1,-3.7,GO:0098828,modulation of inhibitory postsynaptic potential,M1,1,0
1,-2.5,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,M1,1,0
1,-3.8,GO:0003071,renal system process involved in regulation of systemic arterial blood pressure,M1,1,0
1,-5.3,GO:0090303,positive regulation of wound healing,M1,1,0
1,-2.3,hsa00052,Galactose metabolism,M1,1,0
1,-3,GO:0046546,development of primary male sexual characteristics,M1,1,0
1,-2.2,GO:0034032,purine nucleoside bisphosphate metabolic process,M1,1,0
1,-3.3,GO:0043065,positive regulation of apoptotic process,M1,1,0
1,-2.8,hsa04071,Sphingolipid signaling pathway,M1,1,0
1,-2.4,GO:0001975,response to amphetamine,M1,1,0
1,-8.1,GO:0045860,positive regulation of protein kinase activity,M1,1,0
1,-9.8,R-HSA-382551,Transport of small molecules,M1,1,0
1,-3.1,GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,M1,1,0
1,-3.6,GO:0006885,regulation of pH,M1,1,0
1,-4.7,GO:0010811,positive regulation of cell-substrate adhesion,M1,1,0
1,-4,GO:0036293,response to decreased oxygen levels,M1,1,0
1,-2.2,WP4963,p53 transcriptional gene network,M1,1,0
1,-5.2,GO:0001894,tissue homeostasis,M1,1,0
1,-3.6,GO:0071214,cellular response to abiotic stimulus,M1,1,0
1,-3.5,GO:0071624,positive regulation of granulocyte chemotaxis,M1,1,0
1,-8.3,GO:0072503,cellular divalent inorganic cation homeostasis,M1,1,0
1,-9.7,GO:0006820,anion transport,M1,1,0
1,-2.2,GO:0016053,organic acid biosynthetic process,M1,1,0
1,-2.3,GO:0043254,regulation of protein-containing complex assembly,M1,1,0
1,-3.5,GO:0032328,alanine transport,M1,1,0
1,-4,GO:0001505,regulation of neurotransmitter levels,M1,1,0
1,-8.3,GO:0051345,positive regulation of hydrolase activity,M1,1,0
1,-2.3,GO:0006688,glycosphingolipid biosynthetic process,M1,1,0
1,-4.2,WP4142,Metabolism of spingolipids in ER and Golgi apparatus,M1,1,0
1,-6.5,GO:0009636,response to toxic substance,M1,1,0
1,-2.2,GO:0030010,establishment of cell polarity,M1,1,0
1,-2.6,GO:0003334,keratinocyte development,M1,1,0
1,-3.5,GO:0071384,cellular response to corticosteroid stimulus,M1,1,0
1,-2.4,GO:0061333,renal tubule morphogenesis,M1,1,0
1,-2.5,GO:0036151,phosphatidylcholine acyl-chain remodeling,M1,1,0
1,-2.3,GO:0000302,response to reactive oxygen species,M1,1,0
1,-2.7,WP4540,Hippo signaling regulation pathways,M1,1,0
1,-5.9,R-HSA-983712,Ion channel transport,M1,1,0
1,-3.2,GO:0072006,nephron development,M1,1,0
1,-3.3,GO:0021543,pallium development,M1,1,0
1,-9.5,GO:0008610,lipid biosynthetic process,M1,1,0
1,-13,GO:0055082,cellular chemical homeostasis,M1,1,0
1,-3.8,GO:0010950,positive regulation of endopeptidase activity,M1,1,0
1,-2.6,GO:0035303,regulation of dephosphorylation,M1,1,0
1,-4,GO:0007043,cell-cell junction assembly,M1,1,0
1,-2.4,GO:0070201,regulation of establishment of protein localization,M1,1,0
1,-2.5,GO:0010758,regulation of macrophage chemotaxis,M1,1,0
1,-4.1,GO:0072112,glomerular visceral epithelial cell differentiation,M1,1,0
1,-5.9,WP5087,Malignant pleural mesothelioma,M1,1,0
1,-2.3,GO:0060560,developmental growth involved in morphogenesis,M1,1,0
1,-4.1,GO:0031644,regulation of nervous system process,M1,1,0
1,-2.7,GO:1903828,negative regulation of protein localization,M1,1,0
1,-3.1,GO:0010656,negative regulation of muscle cell apoptotic process,M1,1,0
1,-4.9,GO:0043406,positive regulation of MAP kinase activity,M1,1,0
1,-3,R-HSA-428157,Sphingolipid metabolism,M1,1,0
1,-5,GO:0000904,cell morphogenesis involved in differentiation,M1,1,0
1,-3.3,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),M1,1,0
1,-3.9,GO:0043413,macromolecule glycosylation,M1,1,0
1,-3.4,R-HSA-500792,GPCR ligand binding,M1,1,0
1,-7,GO:0008283,cell population proliferation,M1,1,0
1,-2.1,GO:0034121,regulation of toll-like receptor signaling pathway,M1,1,0
1,-3.8,WP3614,Photodynamic therapy-induced HIF-1 survival signaling,M1,1,0
1,-5.7,GO:1904062,regulation of cation transmembrane transport,M1,1,0
1,-2.7,GO:0032940,secretion by cell,M1,1,0
1,-4.1,GO:0099537,trans-synaptic signaling,M1,1,0
1,-2,GO:1901021,positive regulation of calcium ion transmembrane transporter activity,M1,1,0
1,-2.9,GO:0002934,desmosome organization,M1,1,0
1,-2.4,GO:0007215,glutamate receptor signaling pathway,M1,1,0
1,-2.4,WP2840,Hair follicle development: cytodifferentiation - part 3 of 3,M1,1,0
1,-4.2,GO:0071675,regulation of mononuclear cell migration,M1,1,0
1,-2.5,GO:0034123,positive regulation of toll-like receptor signaling pathway,M1,1,0
1,-2.4,WP4719,Eicosanoid metabolism via cyclooxygenases (COX),M1,1,0
1,-2.9,GO:0034097,response to cytokine,M1,1,0
1,-3.5,GO:0035315,hair cell differentiation,M1,1,0
1,-4.8,GO:0046474,glycerophospholipid biosynthetic process,M1,1,0
1,-2.7,GO:0009792,embryo development ending in birth or egg hatching,M1,1,0
1,-2.8,R-HSA-5173214,O-glycosylation of TSR domain-containing proteins,M1,1,0
1,-5.8,GO:0140352,export from cell,M1,1,0
1,-2.9,GO:0090288,negative regulation of cellular response to growth factor stimulus,M1,1,0
1,-2.3,GO:0010664,negative regulation of striated muscle cell apoptotic process,M1,1,0
1,-3.8,GO:1901605,alpha-amino acid metabolic process,M1,1,0
1,-2.1,WP4241,Type 2 papillary renal cell carcinoma,M1,1,0
1,-2.6,GO:0043030,regulation of macrophage activation,M1,1,0
1,-5.2,GO:0007420,brain development,M1,1,0
1,-3.1,GO:2001257,regulation of cation channel activity,M1,1,0
1,-3.2,GO:0070474,positive regulation of uterine smooth muscle contraction,M1,1,0
1,-2.9,GO:0071320,cellular response to cAMP,M1,1,0
1,-2.7,GO:0034331,cell junction maintenance,M1,1,0
1,-2.1,GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,M1,1,0
1,-2,GO:0002090,regulation of receptor internalization,M1,1,0
1,-4,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,M1,1,0
1,-2.4,GO:0010667,negative regulation of cardiac muscle cell apoptotic process,M1,1,0
1,-2.2,GO:0046676,negative regulation of insulin secretion,M1,1,0
1,-3.7,GO:0006790,sulfur compound metabolic process,M1,1,0
1,-3.1,GO:0042491,inner ear auditory receptor cell differentiation,M1,1,0
1,-2.8,WP2447,Amyotrophic lateral sclerosis (ALS),M1,1,0
1,-2.9,GO:0009617,response to bacterium,M1,1,0
1,-2.7,GO:0061326,renal tubule development,M1,1,0
1,-2.1,R-HSA-112040,G-protein mediated events,M1,1,0
1,-5.6,GO:1990961,xenobiotic detoxification by transmembrane export across the plasma membrane,M1,1,0
1,-2.9,GO:0071248,cellular response to metal ion,M1,1,0
1,-3.1,GO:0071474,cellular hyperosmotic response,M1,1,0
1,-3.2,GO:0048568,embryonic organ development,M1,1,0
1,-4.1,GO:0045927,positive regulation of growth,M1,1,0
1,-2.1,GO:1905332,positive regulation of morphogenesis of an epithelium,M1,1,0
1,-4.4,GO:0030198,extracellular matrix organization,M1,1,0
1,-2,GO:1902475,L-alpha-amino acid transmembrane transport,M1,1,0
1,-9.8,GO:0043270,positive regulation of ion transport,M1,1,0
1,-2.4,GO:0010763,positive regulation of fibroblast migration,M1,1,0
1,-2.1,R-HSA-71387,Metabolism of carbohydrates,M1,1,0
1,-2.1,hsa04916,Melanogenesis,M1,1,0
1,-3.7,GO:0097151,positive regulation of inhibitory postsynaptic potential,M1,1,0
1,-2.8,GO:0072593,reactive oxygen species metabolic process,M1,1,0
1,-7,GO:0000902,cell morphogenesis,M1,1,0
1,-2.1,R-HSA-4420097,VEGFA-VEGFR2 Pathway,M1,1,0
1,-5.5,GO:1903509,liposaccharide metabolic process,M1,1,0
1,-2.6,GO:0055062,phosphate ion homeostasis,M1,1,0
1,-2.8,GO:0030177,positive regulation of Wnt signaling pathway,M1,1,0
1,-2.2,WP3611,Photodynamic therapy-induced AP-1 survival signaling,M1,1,0
1,-2.9,hsa05143,African trypanosomiasis,M1,1,0
1,-2.5,GO:0030104,water homeostasis,M1,1,0
1,-2.8,GO:0032835,glomerulus development,M1,1,0
1,-2.7,GO:0006040,amino sugar metabolic process,M1,1,0
1,-2.3,GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,M1,1,0
1,-4.2,GO:0051180,vitamin transport,M1,1,0
1,-4.8,hsa00250,"Alanine, aspartate and glutamate metabolism",M1,1,0
1,-2.1,GO:0003002,regionalization,M1,1,0
1,-2.5,GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,M1,1,0
1,-14,GO:0006873,cellular ion homeostasis,M1,1,0
1,-4.5,hsa04512,ECM-receptor interaction,M1,1,0
1,-4.1,GO:0015804,neutral amino acid transport,M1,1,0
1,-2.1,GO:2001236,regulation of extrinsic apoptotic signaling pathway,M1,1,0
1,-2.1,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,M1,1,0
1,-4.6,GO:0002688,regulation of leukocyte chemotaxis,M1,1,0
1,-2.8,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,M1,1,0
1,-6.3,GO:0043583,ear development,M1,1,0
1,-4.8,GO:0010951,negative regulation of endopeptidase activity,M1,1,0
1,-4.2,GO:0061028,establishment of endothelial barrier,M1,1,0
1,-2.5,GO:0031668,cellular response to extracellular stimulus,M1,1,0
1,-4,R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,M1,1,0
1,-4.6,R-HSA-1483257,Phospholipid metabolism,M1,1,0
1,-5.2,GO:0031099,regeneration,M1,1,0
1,-2,GO:1903169,regulation of calcium ion transmembrane transport,M1,1,0
